Matsumoto Kazuya, Nakanishi Hideki, Kubo Yoshiaki, Yokozeki Masahiko, Moriyama Keiji
Department of Plastic and Reconstructive Surgery, The University of Tokushima School of Medicine, Tokushima, Japan.
J Med Invest. 2003 Aug;50(3-4):117-25.
Distraction osteogenesis has been applied to the craniofacial skeleton as well as the long bones of the extremities. This technique does not require bone grafting and allows correction of craniofacial deformities with less invasion. Moreover, the distraction procedures can expand the overlying soft tissues simultaneously. We determined the indications of distraction osteogenesis, analyzed the types of devices available, and examined patients treated with distraction for the mandible, midface, and cranium. In all three sites, the devices tended to be the buried type and made of absorbable materials. Administration of some cytokines for shortening the consolidation period may be considered. Among disorders indicated for distraction osteogenesis, there are several syndromic craniosynostoses, which involve mutations in the fibroblast growth factor receptor (FGFR) 2 gene. The FGFR 2 mutation was suggested to clinically accelerate osteogenesis at the distraction site. The usefulness and appropriateness of the distraction protocol must be assessed for each individual disorder. Although distraction osteogenesis in the craniofacial skeleton has advanced technologically, all possible risks must be discussed with the patient and family members when obtaining preoperative informed consent, especially until establishment of fully safe distraction procedures.
牵引成骨术已应用于颅面骨骼以及四肢长骨。该技术无需植骨,且能以较小的侵袭性矫正颅面畸形。此外,牵引过程可同时扩张覆盖其上的软组织。我们确定了牵引成骨术的适应症,分析了可用装置的类型,并检查了接受下颌骨、中面部和颅骨牵引治疗的患者。在所有这三个部位,装置往往为埋藏式且由可吸收材料制成。可考虑使用某些细胞因子来缩短巩固期。在牵引成骨术适用的疾病中,有几种综合征性颅缝早闭症,它们涉及成纤维细胞生长因子受体(FGFR)2基因的突变。FGFR 2突变在临床上被认为会加速牵引部位的成骨。必须针对每种个体疾病评估牵引方案的有效性和适用性。尽管颅面骨骼的牵引成骨术在技术上已有进展,但在获得术前知情同意时,必须与患者及家属讨论所有可能的风险,特别是在完全安全的牵引程序确立之前。